U.S. Office-based Labs Market Size, Share & Trends Analysis Report By Modality, By Service, By Specialist And Segment Forecasts From 2022 To 2030

The U.S. office-based labs market size was valued at USD 9.6 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 7.46% from 2022 to 2030. The primary factors influencing the market are the increasing number of surgical operations that are being conducted in outpatient settings and the high prevalence of vascular disorders in the U.S.    

Vascular illnesses are becoming more common in the U.S. According to an AHA article from June 2021, 7% of individuals in the U.S. have peripheral arterial disease (PAD), which affects around 8.5 million people. Cardiovascular diseases are now more common than they were ten years ago, and this trend is predicted to accelerate exponentially. Over the past decade, the number of people with CVDs and PADs has increased by 13% in the United States. PADs often result in ischemic amputations and raise the risk of heart attack and stroke. This has driven the need for vascular surgical operations.

There are numerous service providers in the U.S., including National Cardiovascular Partners, Envision Healthcare, and Surgery Partners, who have been offering patients office-based surgical solutions and services at competitive prices. Prominent market players such as Philips Healthcare and Siemens Healthineers are collaborating with healthcare providers and medical professionals to set up OBLs, supplying laboratories with the necessary equipment, and offering end-to-end solutions.

The range of surgical treatments performed in office settings is expanding as a result of evolving reimbursement regulations for surgical operations. The Centers for Medicare and Medicaid Services expanded the types of surgical procedures that are covered when done in outpatient settings in 2021 and suggested new guidelines for operations that are reimbursed in ASCs.

U.S. Office-based Labs Market Report Key Takeaways

• The single-specialty OBL modality segment accounted for the largest revenue share in 2021 and the hybrid office-based labs segment is projected to register the highest CAGR by 2030
• The growing popularity of digital health solutions, such as integrated care Electronic Health Records (EHRs) and other digital health solutions have fueled the growth of multi-specialty labs
• Based on the services segment, vascular procedures are the commonly performed operations in OBL settings and among vascular operations, peripheral vascular interventions (PVI) are mostly offered to patients
• Based on geography, North America dominated the overall market in 2021 as in the U.S. approximately 70% of the surgical procedures are done in outpatient settings

U.S. Office-based Labs Market Segments

• U.S. Office-based Labs Modality Outlook (Revenue, USD Million, 2017 - 2030)
  • Single-specialty Labs
  • Multi-specialty Labs
  • Hybrid Labs
• U.S. Office-based Labs Service Outlook (Revenue, USD Million, 2017 - 2030)
  • Peripheral Vascular Intervention
  • Endovascular Interventions
  • Cardiac
  • Interventional Radiology
  • Venous
  • Others
• U.S. Office-based Labs Specialty Outlook (Revenue, USD Million, 2017 - 2030)
  • Vascular Surgeons
  • Interventional Cardiologist
  • Interventional Radiologists
  • Others
• List of Key Players in the U.S. Office-based Labs (OBLs) Market
  • Manufacturers
    • Koninklijke Philips N.V
    • GE Healthcare
    • Siemens Healthineers AG
    • Medtronic PLC
    • Boston Scientific Corp.
    • Abbott
    • Cardiovascular Systems, Inc.
  • Service Providers
    • Envision Healthcare
    • Surgery Care Associates, Inc. (SCA)
    • Surgery Partners
    • National Cardiovascular Partners
    • Cardiovascular Coalition
    • TH Medical
    • Service Providers